LysoPC(15:0/0:0)
|
Basic information |
| Metabolite name | LysoPC(15:0/0:0) |
 | HMDB0010381 |
 |
C04230 |
 |
24779458 |
| Synonyms | LysoPC(15:0) |
| No. of studies | 13 |
|
Basic information |
| Metabolite name | LysoPC(15:0/0:0) |
| HMDB0010381 |
|
C04230 |
|
24779458 |
| Synonyms | LysoPC(15:0) |
| No. of studies | 13 |
|
Relationship between LysoPC(15:0/0:0) and depression (count: 13) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M048 | Type1 | CVS group vs. control group | Hippocampus | Wistar rat | Down |
| Study M048 | Type2 | CVS + CSGS group vs. CVS group | Hippocampus | Wistar rat | Up |
| Study M1072 | Type1 | CUMS group vs. control group | Faece | Cynomolgus monkey | Down |
| Study M1117 | Type1 | MDD group vs. control group, Russian cohort | Plasma | Human | Down |
| Study M1117 | Type1 | MDD group vs. control group, Chinese cohort | Plasma | Human | Up |
| Study M210 | Type1 | CUMS group vs. control group | Serum | Sprague-Dawley rat | Up |
| Study M210 | Type2 | CUMS + curcumin group vs. CUMS group | Serum | Sprague-Dawley rat | Down |
| Study M210 | Type2 | CUMS + venlafaxine group vs. CUMS group | Serum | Sprague-Dawley rat | Down |
| Study M457 | Type1 | CUMS group vs. control group | Serum | Sprague-Dawley rat | Up |
| Study M457 | Type2 | CUMS + D6 doses of PBR group vs. CUMS group | Serum | Sprague-Dawley rat | Down |
| Study M457 | Type3 | D6 doses of PBR group vs. control group | Serum | Sprague-Dawley rat | Down |
| Study M512 | Type1 | CUMS group vs. control group | Plasma | Goto-Kakizaki rat | Down |
| Study M582 | Type2 | CUMS + fluoxetine group vs. CUMS group | Serum | C57BL/6N mouse | Down |
| Study M582 | Type3 | control + fluoxetine group vs. control group | Serum | C57BL/6N mouse | Down |
| Study M681 | Type1 | CUMS group vs. control group | Serum | Sprague-Dawley rat | Down |
| Study M681 | Type2 | CUMS + Chaihu Shu Gan San group vs. CUMS group | Serum | Sprague-Dawley rat | Up |
| Study M690 | Type2 | CUMS + high dose of Zhi-zi-chi decoction group vs. CUMS group | Serum | Balb/c mouse | Down |
| Study M712 | Type1 | depression group vs. control group | Prefrontal cortex | Cynomolgus monkey | Down |
| Study M867 | Type1 | CUMS group vs. control group | Brain | Sprague-Dawley rat | Down |
| Study M907 | Type1 | MDD group vs. control group | Plasma | Human | Down |
| Study M942 | Type1 | CUMS group vs. control group | Hippocampus | C57BL/6 mouse | Up |
| Study M942 | Type2 | CUMS + berberine group vs. CUMS group | Hippocampus | C57BL/6 mouse | Down |